CFLAR and renal carcinoma: Because miR-708 can inhibit c-FLIPL expression by directly inhibiting the c-FLIPL transcript, we next investigated whether reduction of c-FLIPL expression could explain the increase in sensitivity of renal cancer cells to apoptosis-inducing agents.